Literature DB >> 26660275

Distinct and complementary roles for α and β isoenzymes of PKC in mediating vasoconstrictor responses to acutely elevated glucose.

Robert Jackson1, Sean Brennan1, Peter Fielding1, Mark W Sims1, R A John Challiss2, David Adlam1, Iain B Squire1, Richard D Rainbow1.   

Abstract

BACKGROUND AND
PURPOSE: We investigated the hypothesis that elevated glucose increases contractile responses in vascular smooth muscle and that this enhanced constriction occurs due to the glucose-induced PKC-dependent inhibition of voltage-gated potassium channels. EXPERIMENTAL APPROACH: Patch-clamp electrophysiology in rat isolated mesenteric arterial myocytes was performed to investigate the glucose-induced inhibition of voltage-gated potassium (Kv ) current. To determine the effects of glucose in whole vessel, wire myography was performed in rat mesenteric, porcine coronary and human internal mammary arteries. KEY
RESULTS: Glucose-induced inhibition of Kv was PKC-dependent and could be pharmacologically dissected using PKC isoenzyme-specific inhibitors to reveal a PKCβ-dependent component of Kv inhibition dominating between 0 and 10 mM glucose with an additional PKCα-dependent component becoming evident at concentrations greater than 10 mM. These findings were supported using wire myography in all artery types used, where contractile responses to vessel depolarization and vasoconstrictors were enhanced by increasing bathing glucose concentration, again with evidence for distinct and complementary PKCα/PKCβ-mediated components. CONCLUSIONS AND IMPLICATIONS: Our results provide compelling evidence that glucose-induced PKCα/PKCβ-mediated inhibition of Kv current in vascular smooth muscle causes an enhanced constrictor response. Inhibition of Kv current causes a significant depolarization of vascular myocytes leading to marked vasoconstriction. The PKC dependence of this enhanced constrictor response may present a potential therapeutic target for improving microvascular perfusion following percutaneous coronary intervention after myocardial infarction in hyperglycaemic patients.
© 2015 The British Pharmacological Society.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26660275      PMCID: PMC4761094          DOI: 10.1111/bph.13399

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  62 in total

1.  Calcium and diabetic vascular dysfunction. Focus on "Elevated Ca(2+) sparklet activity during acute hyperglycemia and diabetes in cerebral arterial smooth muscle cells".

Authors:  Kathryn M Dunn; Mark T Nelson
Journal:  Am J Physiol Cell Physiol       Date:  2009-11-11       Impact factor: 4.249

2.  PKC-mediated toxicity of elevated glucose concentration on cardiomyocyte function.

Authors:  Mark W Sims; James Winter; Sean Brennan; Robert I Norman; G André Ng; Iain B Squire; Richard D Rainbow
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-08-15       Impact factor: 4.733

3.  Glucose reduces endothelin inhibition of voltage-gated potassium channels in rat arterial smooth muscle cells.

Authors:  R D Rainbow; M E L Hardy; N B Standen; N W Davies
Journal:  J Physiol       Date:  2006-07-06       Impact factor: 5.182

4.  Key role of Kv1 channels in vasoregulation.

Authors:  Tim T Chen; Kevin D Luykenaar; Emma J Walsh; Michael P Walsh; William C Cole
Journal:  Circ Res       Date:  2006-06-01       Impact factor: 17.367

5.  Regulation of intracerebral arteriolar tone by K(v) channels: effects of glucose and PKC.

Authors:  Stephen V Straub; Helene Girouard; Paul E Doetsch; Rachael M Hannah; M Keith Wilkerson; Mark T Nelson
Journal:  Am J Physiol Cell Physiol       Date:  2009-07-15       Impact factor: 4.249

6.  Prognostic value of admission blood glucose concentration and diabetes diagnosis on survival after acute myocardial infarction: results from 4702 index cases in routine practice.

Authors:  Ian B Squire; Christopher P Nelson; Leong L Ng; David R Jones; Kent L Woods; Paul C Lambert
Journal:  Clin Sci (Lond)       Date:  2010-04       Impact factor: 6.124

7.  Acute hyperglycemia adversely affects stroke outcome: a magnetic resonance imaging and spectroscopy study.

Authors:  Mark W Parsons; P Alan Barber; Patricia M Desmond; Tracey A Baird; David G Darby; Graham Byrnes; Brian M Tress; Stephen M Davis
Journal:  Ann Neurol       Date:  2002-07       Impact factor: 10.422

8.  Activation of protein kinase C by elevation of glucose concentration: proposal for a mechanism in the development of diabetic vascular complications.

Authors:  T S Lee; K A Saltsman; H Ohashi; G L King
Journal:  Proc Natl Acad Sci U S A       Date:  1989-07       Impact factor: 11.205

9.  Effect of intracoronary serotonin on coronary vessels in patients with stable angina and patients with variant angina.

Authors:  E P McFadden; J G Clarke; G J Davies; J C Kaski; A W Haider; A Maseri
Journal:  N Engl J Med       Date:  1991-03-07       Impact factor: 91.245

10.  Distinct and complementary roles for α and β isoenzymes of PKC in mediating vasoconstrictor responses to acutely elevated glucose.

Authors:  Robert Jackson; Sean Brennan; Peter Fielding; Mark W Sims; R A John Challiss; David Adlam; Iain B Squire; Richard D Rainbow
Journal:  Br J Pharmacol       Date:  2016-02-08       Impact factor: 8.739

View more
  10 in total

1.  Propofol induces excessive vasodilation of aortic rings by inhibiting protein kinase Cβ2 and θ in spontaneously hypertensive rats.

Authors:  Yan Wang; Quanhong Zhou; Bin Wu; Huixuan Zhou; Xiaoli Zhang; Wei Jiang; Li Wang; Aizhong Wang
Journal:  Br J Pharmacol       Date:  2017-05-10       Impact factor: 8.739

Review 2.  Regulation of voltage-gated potassium channels in vascular smooth muscle during hypertension and metabolic disorders.

Authors:  Madeline Nieves-Cintrón; Arsalan U Syed; Matthew A Nystoriak; Manuel F Navedo
Journal:  Microcirculation       Date:  2018-01       Impact factor: 2.628

3.  Adenylyl cyclase 5-generated cAMP controls cerebral vascular reactivity during diabetic hyperglycemia.

Authors:  Arsalan U Syed; Gopireddy R Reddy; Debapriya Ghosh; Maria Paz Prada; Matthew A Nystoriak; Stefano Morotti; Eleonora Grandi; Padmini Sirish; Nipavan Chiamvimonvat; Johannes W Hell; Luis F Santana; Yang K Xiang; Madeline Nieves-Cintrón; Manuel F Navedo
Journal:  J Clin Invest       Date:  2019-06-04       Impact factor: 14.808

4.  A Gs-coupled purinergic receptor boosts Ca2+ influx and vascular contractility during diabetic hyperglycemia.

Authors:  Maria Paz Prada; Arsalan U Syed; Olivia R Buonarati; Gopireddy R Reddy; Matthew A Nystoriak; Debapriya Ghosh; Sergi Simó; Daisuke Sato; Kent C Sasse; Sean M Ward; Luis F Santana; Yang K Xiang; Johannes W Hell; Madeline Nieves-Cintrón; Manuel F Navedo
Journal:  Elife       Date:  2019-03-01       Impact factor: 8.140

5.  Small-Molecule G Protein-Coupled Receptor Kinase Inhibitors Attenuate G Protein-Coupled Receptor Kinase 2-Mediated Desensitization of Vasoconstrictor-Induced Arterial Contractions.

Authors:  Richard D Rainbow; Sean Brennan; Robert Jackson; Alison J Beech; Amal Bengreed; Helen V Waldschmidt; John J G Tesmer; R A John Challiss; Jonathon M Willets
Journal:  Mol Pharmacol       Date:  2018-07-06       Impact factor: 4.436

Review 6.  Purinergic Signaling During Hyperglycemia in Vascular Smooth Muscle Cells.

Authors:  Miguel Martin-Aragon Baudel; Ricardo Espinosa-Tanguma; Madeline Nieves-Cintron; Manuel F Navedo
Journal:  Front Endocrinol (Lausanne)       Date:  2020-05-22       Impact factor: 5.555

7.  Type 2 diabetes progression differently affects endothelial function and vascular contractility in the aorta and the pulmonary artery.

Authors:  Bernardete F Melo; Jesus Prieto-Lloret; Marlene D Cabral; Fatima O Martins; Inês B Martins; Joana F Sacramento; Pedro Ruivo; Tânia Carvalho; Silvia V Conde
Journal:  Sci Rep       Date:  2021-03-15       Impact factor: 4.379

8.  Effect of fasting blood glucose on risk of new-onset hypertension in rural Chinese population: a 15-year follow-up cohort.

Authors:  Jing Liu; Nan N Cheng; Zi Y Zhou; Yue Zhang; Jie Yang; Li S Liu; Yun Song; Xiao Huang; Gen F Tang; Bin Y Wang; Xian H Qin; Xi P Xu; Xiang Q Kong
Journal:  BMC Cardiovasc Disord       Date:  2021-11-08       Impact factor: 2.298

9.  Selective protein kinase C inhibition switches time-dependent glucose cardiotoxicity to cardioprotection.

Authors:  Sean Brennan; Simona Esposito; Muhammad I M Abdelaziz; Christopher A Martin; Samir Makwana; Mark W Sims; Iain B Squire; Parveen Sharma; Amy E Chadwick; Richard D Rainbow
Journal:  Front Cardiovasc Med       Date:  2022-09-07

10.  Distinct and complementary roles for α and β isoenzymes of PKC in mediating vasoconstrictor responses to acutely elevated glucose.

Authors:  Robert Jackson; Sean Brennan; Peter Fielding; Mark W Sims; R A John Challiss; David Adlam; Iain B Squire; Richard D Rainbow
Journal:  Br J Pharmacol       Date:  2016-02-08       Impact factor: 8.739

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.